在COVID-19大流行期间,性结肠炎患者的进展情况
Toshikuni Suda1, Morio Takahashi2, Yasumi Katayama3
1Division of Gastroenterology, Dokkyo Medical University Saitama Medical Center, Saitama 343-8555, Japan. toshikuni.suda@gmail.com.
World journal of clinical cases
|August 28, 2023
概括
性结肠炎 (UC) 患者
科学领域:
- 胃肠道学和免疫学
- 传染病与公共卫生问题
背景情况:
- 最初的COVID-19浪潮加剧了性结肠炎 (UC),可能是由于压力.
- 随后的流行病浪潮引入了慢性压力,需要对UC患者的长期影响进行调查.
研究的目的:
- 评估持续的COVID-19大流行压力对UC疾病活动和患者结果的影响.
- 为了评估UC患者的状况,超出了最初的流行浪潮.
主要方法:
- 2020年的一项研究中的289名性结肠炎门诊患者的队列在2021年和2022年被重新评估.
- 使用UC-Disease Activity Index (UC-DAI),内镜粘膜外观和Matts病理等级来测量疾病活性.
主要成果:
- UC-DAI分数最初在第一波COVID-19期间恶化,到2021年显著改善,并在2022年保持稳定.
- 马特斯的成绩在2021年显著恢复,在2022年稳定,这表明粘膜愈合得到改善.
- 患者的特征在整个研究年保持一致,支持观察到的变化的有效性.
结论:
- 尽管持续的流行病压力,性结肠炎疾病活动和内镜检查结果在2021年显著改善,并在2022年持续.
- 这些发现表明,UC患者即使在长期的公共卫生危机中也可以实现疾病缓解和稳定.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
213
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
213
Drugs for Treatment of Ulcerative Colitis in IBD
173
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
173
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
354
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
354
Inflammatory Bowel Disease V: Surgical Management
167
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
167
Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
Inflammatory Bowel Disease II: Crohn's Disease
285
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
285


